Strong expression of CD133 is associated with increased cholangiocarcinoma progression

AIM: To determine the role of CD133 in cholangiocarcinoma progression. METHODS: CD133 protein expression was evaluated by immunohistochemistry in 34 cholangiocarcinoma specimens. In addition, proliferation, chemoresistance and invasive properties of CD133-enriched (CD133(+)) and CD133-depleted (CD13...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Leelawat, Kawin, Thongtawee, Taweesak, Narong, Siriluck, Subwongcharoen, Somboon, Treepongkaruna, Sa-ad
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2011
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063913/
https://ncbi.nlm.nih.gov/pubmed/21448425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i9.1192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars